Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma

NCT03672318 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Immune System Diseases

Interventions

DRUG: CAR138 T Cells

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]